Resúmenes Epistemonikos

← vista completa

Publicado el 29 de diciembre de 2017 | http://doi.org/10.5867/medwave.2017.09.7121

¿Es efectiva la lidocaína endovenosa para disminuir el dolor y acelerar la recuperación postoperatoria?

Is intravenous lidocaine effective for decreasing pain and speeding up recovery after surgery?

María Magdalena González, Fernando Altermatt

Abstract

INTRODUCTION Lidocaine is widely used in anesthesia due to its multiple properties, including its role as analgesic. However, it is not entirely clear which are the real benefits of its use in the perioperative setting.

METHODS To answer this question we used Epistemonikos, the largest database of systematic reviews in health, which is maintained by screening multiple information sources, including MEDLINE, EMBASE, Cochrane, among others. We extracted data from the systematic reviews, reanalyzed data of primary studies, conducted a meta-analysis and generated a summary of findings table using the GRADE approach.

RESULTS AND CONCLUSIONS We identified 15 systematic reviews including 53 studies overall, all of them randomized controlled trials. We concluded the use of intravenous perioperative lidocaine probably results in a clinically irrelevant difference in pain and length of hospital stay, but it probably prevents postoperative nausea and vomiting.

Problem

There are different alternatives used as adjuvants in the various anesthetics techniques, with the objective of diminishing postoperative symptoms and accelerating recovery. It has been proposed that lidocaine, a local anesthetic belonging to the group of the aminoamides which acts by inhibiting sodium channels, would have analgesics effects, among others, that would make it a good alternative in the surgical setting. Nevertheless, it is not yet clear whether its effects bring a real benefit for patients, and also if it is a safe intervention.

Methods

To answer the question, we used Epistemonikos, the largest database of systematic reviews in health, which is maintained by screening multiple information sources, including MEDLINE, EMBASE, Cochrane, among others, to identify systematic reviews and their included primary studies. We extracted data from the identified reviews and reanalyzed data from primary studies included in those reviews. With this information, we generated a structured summary denominated FRISBEE (Friendly Summary of Body of Evidence using Epistemonikos) using a pre-established format, which includes key messages, a summary of the body of evidence (presented as an evidence matrix in Epistemonikos), meta-analysis of the total of studies when it is possible, a summary of findings table following the GRADE approach and a table of other considerations for decision-making. 

Key messages

  • The use of perioperative lidocaine probably leads to a clinically irrelevant reduction in pain at rest at 24 hours, time to first flatus and length of hospital stay.
  • The use of perioperative lidocaine probably prevents postoperative nausea and vomiting.
  • Considering the marginal clinical relevance of the benefits and the higher costs in comparison to other pharmacological alternatives for postoperative nausea and vomiting, the balance between benefits, risks and costs is not favorable.

About the body of evidence for this question

What is the evidence.
See evidence matrix  in Epistemonikos later

We identified 15 systematic reviews [1],[2],[3],[4],[5],[6],[7],[8],[9],
[10],[11],[12],[13],[14],[15], including 53 primary studies overall, reported in 55 references [16],[17],[18],[19],[20],[21],[22],[23],
[24],[25],[26],[27],[28],[29],[30],[31],[32],[33],[34],[35],[36],
[37],[38],[39],[40],[41],[42],[43],[44],[45],[46],[47],[48],[49],
[50],[51],[52],[53],[54],[55],[56],[57],[58],[59],[60],[61],[62],
[63],[64],[65],[66],[67],[68],[69],[70]. All of the studies corresponded to randomized controlled trials.

One of the reviews [10] presented data from one trial that was not included in any other review (Harvey 2006), in a way in which it was not possible to reanalyze it. The reference to this trial is not included in the review, it was not possible to identify it by other means and the author did not reply after to our contact.

What types of patients were included*

Twenty five trials included adults from 18 to 75 years old [16],[17],
[18],[19],[20],[21],[22],[23],[24],[25],[26],[27],[28],[29],[31],
[32],[33],[34],[35],[36],[38],[39],[40],[41],[42] and in 28 trials this information was not available [43],[44],[45],[46],[47],[48],[49],[50],
[51],[52],[53],[54],[55],[56],[57],[58],[59],[60],[61],[62],[63],[64],
[65],[66],[67],[68],[69],[70].

Seven trials only included women [18],[21],[42],[44],[49],[50],[52], three included only men [26],[53],[60], the remaining 43 trials did not restrict by sex.

Fourteen trials included ASA I-II patients [16],[18],[19],[28],[34],[36],[41],
[42],[44],[50],[52],[53],[65],[68], ten ASA I-III [20],[21],[22],[24],
[31],[35],[38],[39],[60],[69], one trial included ASA I patients only [66] and in 28 trials this information was not available.

In 24 trials the patients underwent abdominal surgery; of these, 13 only included digestive surgery [17],[22],[24],[27],[28],[39],[41],
[48],[58],[63],[65],[67],[68], five gynecological [21],[42],[44],[49],[50], three urological [53],[60],[69], in two trials the type of abdominal surgery was not specified [16],[59], and in one it corresponded to inguinal herniorrhaphy [25]. Seven trials included cardiovascular surgeries; four only vascular [23],[26],[29],[40], two cardiac and vascular surgeries [33],[62], and one only included cardiac surgeries [32]. Of the remaining, three trials addressed breast surgery [18],[38],[52], two spine surgery [20],[55], two thoracic surgery [19],[35], one total hip arthroplasty [61], one diverse ophthalmologic surgeries [36], one outpatient surgery under general anesthesia [31] and two otorhinolaryngology surgery; one functional endoscopic sinus surgery [34] and one elective tonsillectomy [66]. Ten trials did not report the type of surgery [43],[45],[46],[47],[51],[54],[56],[57],[64],[70].

Twenty-two trials excluded patients with chronic pain conditions, chronic pain treatments or pain treatment in the last week with any analgesic drug [19],[21],[22],[24],[25],[28],[34],[35],[39],[41],[42],
[44],[48],[49],[52],[53],[59],[60],[61],[65],[68],[69].

What types of interventions were included*

All of the trials used intravenous systemic lidocaine.

Forty seven trials started lidocaine intraoperatively; of these, forty six initiated it before skin incision [16],[17],[18],[19],[20],[21],[22],
[23],[24],[25],[26],[27],[28],[29],[31],[32],[33],[34],[35],[36],
[38],[39],[41],[42],[44],[47],[48],[49],[50],[51],[52],[53],[55],
[56],[57],[59],[60],[61],[62],[63],[64],[65],[66],[67],[68],[69], and one before the opening of the pericardium [40]. 

Forty two trials used a lidocaine bolus (1 mg/kg to 3 mg/kg) followed by an infusion (20 μg/kg/min to 4 mg/min); from these, 17 maintained the infusion only during the intraoperative period [18],
[25],[27],[28],[29],[34],[35],[40],[41],[42],[44],[48],[49],[51],
[55],[56],[65], 12 until completing 24 hours [16],[22],[31],[33],[38],
[50],[52],[53],[59],[61],[64],[66], nine for 24 hours postoperatively [17],[21],[24],[39],[57],[60],[63],[67],[69], two for 48 hours postoperatively [32],[62], one for 48 hours postoperatively or discharge from the intensive care unit [23] and one did not report when the infusion ended [26]. Four trials did not use a bolus, but only an infusion (33 μg/kg/min to 3 mg/kg/h), from which three kept it only during the intraoperative period [19],[36],[68] and one until discharge from post-anesthesia care unit or for eight hours [20]. One trial used three lidocaine boluses (2 mg/kg) during the intraoperative period and after that a PCA (patient-controlled analgesia) pump of lidocaine was used (23 mg) according to patient’s requirement, without reporting an end time [47].

Four trials started lidocaine postoperatively; one as a bolus (1.5 mg/kg) and then continued with an infusion (2 mg/kg/h) for two hours [43]; of the remaining three, one used lidocaine infusion (60 mg/h) for 24 hours [54] and two a PCA without referring an end time [45],[46].

One trial started lidocaine preoperatively [58] with a bolus (1.5 mg/kg) followed by an infusion (2 mg/kg/h) only during the intraoperative period.

It was not possible to extract data related to the characteristics from one trial [70] because it was included in only one systematic review [15], and the author did not reply after attempting to contact him.

One trial was included in a systematic review with preliminary data before being published [35].

All of the trials compared lidocaine against placebo or no treatment.

What types of outcomes
were measured

The outcome were grouped by the systematics reviews as follows: Postoperative pain, intraoperative and postoperative analgesic consumption, chronic pain, opioid related adverse effects,  postoperative nausea and vomiting, postoperative ileus and functional gastrointestinal recovery (evaluated by time to first flatus, feces, or bowel movement), length of hospital stay and length of post-anesthesia care unit stay, surgical complications, adverse events, mortality, cognitive outcomes, patient satisfaction, cessation of the intervention, systemic lidocaine toxicity, plasma levels of cytokines. 

* The information about primary studies is extracted from the systematic reviews identified, unless otherwise specified.

Summary of Findings

The information about the effects of the intravenous systemic lidocaine is based on 37 randomized trials including 2253 patients [16],[17],[18],[20],[21],[22],[23],[24],[25],[27],[28],[31],[32],[33],[35],[39],[40],[41],[42],[44],[48],[49],[51],[52],[53],[54],[57],[58],[59],[60],[61],[62],[63],[65],[66],[68],[69]. Twenty five trials reported the outcome pain at rest at 24 hours [16],[17],[18],[20],[22],[24],[25],[27],[28],[31],[35],[39],[41],[42],[44],[52],[53],[57],[58],[59],[60],[61],[65],[68],[69], 16 reported time to first flatus [18],[22],[24],[25],[28],[41],[51],[53],[54],[57],[59],[60],[63],[65],[68],[69], 24 measured length of hospital stay [18],[20],[22],[23],[24],[25],[27],[28],[32],[33],[39],[40],[41],[48],[51],[53],[54],[57],[58],[59],[60],[61],[62],[69] and 24 reported postoperative nausea and vomiting [16],[17],[18],[20],[21],[24],[25],[27],[28],[31],[35],[39],[41],[44],[49],[57],[58],[59],[60],[63],[65],[66],[68],[69].

The summary of findings is the following:

  • The use of perioperative lidocaine probably leads to a clinically irrelevant reduction of pain at rest at 24 hours. The certainty of the evidence is moderate.
  • The use of perioperative lidocaine probably leads to a clinically irrelevant reduction of time to first flatus. The certainty of the evidence is moderate.
  • The use of perioperative lidocaine probably leads to a clinically irrelevant reduction of length of hospital stay. The certainty of the evidence is moderate.
  • The use of perioperative lidocaine probably prevents postoperative nausea and vomiting. The certainty of the evidence is moderate.

Other considerations for decision-making

To whom this evidence does and does not apply
  • The results of this summary apply to adult patients without chronic pain, who undergo surgery under general anesthesia including digestive, urological, ginaecological, breast, thoracic, vascular, cardiac, spine, otorhinolaringologic, traumatologic and ophtalmologic surgery.
  • We believe this evidence is better applied to patients who undergo abdominal surgeries due to the number of trials evaluating this specific group.
About the outcomes included in this summary
  • The outcomes selected are those considered critical for decision-making by the authors of this summary. Considering the wide variety of outcomes reported by the systematic reviews, the ones who were chosen were considered to be clinically relevant outcomes (considering, for instance, that opioid consumption would be substitute to pain level). In general, they coincide with the outcomes most frequently reported by the identified reviews.
  • No substitute outcomes were selected, for instance intraoperative consumption of analgesics.
Balance between benefits and risks, and certainty of the evidence
  • Even though it probably prevents postoperative nausea and vomiting, the application of this intervention is more complex than applying other pharmacological interventions for the prevention of postoperative nausea and vomiting.
  • Most trials explicitly excluded patients with a history or suspicion of adverse reactions or hypersensitivity to local anesthetics. Furthermore, as screening for this condition is part of the preanesthetic evaluation, the trials included low-risk patients. Despite this, two systematics reviews [6],[8] reported secondary effects related to lidocaine, which were considered mild and did not require therapeutic intervention.
Resource considerations
  • This intervention probably prevents postoperative nausea and vomiting, but it has a higher cost than other pharmacological alternatives, such as dexamethasone and ondansetron.
  • On the other hand, it is an intervention with little or no benefit, so it does not seem reasonable to make an estimation of the balance between costs and benefits.
What would patients and their doctors think about this intervention
  • Faced with the evidence presented in this summary most clinicians should be inclined against the routine use intravenous systemic lidocaine perioperatively.
  • Even though there is no clear data in the analyzed evidence, the clinicians may be inclined to use intravenous systemic lidocaine perioperatively as an initial approach when other alternatives for the management of postoperative nausea and vomiting are not possible, or in case the patient requires multiple interventions for the prevention of these symptoms, due to high preoperative risk of this condition or in surgeries where it is desirable to avoid the increase of abdominal pressure postoperatively.

Differences between this summary and other sources
  • Most systematics reviews included in this summary reached similar conclusions regarding time to first flatus, postoperative nausea and vomiting, and pain at rest at 24 hours. On postoperative nausea and vomiting, the reviews that did not find an effect posed the explanation would be the low incidence of the event or the insufficient statistical power to detect this difference. On the outcome pain at rest at 24 hours, only one review [13], exclusively including patients with breast surgery, did not find any difference in the reduction of pain. Lastly, length of stay was the outcome with the least agreement between reviews; about half reported there was a significant effect while the other half did not find this effect.
  • The guideline ‘Perioperative Use of Intravenous Lidocaine’ [71] by the American Society of Anesthesiologists mentions lidocaine is effective but its clinical effect varies between surgeries. It would reduce pain in abdominal, spine and thoracic surgeries, and in open prostatectomy, while it would not be effective in abdominal hysterectomy, total hip arthroplasty, and renal surgery. It also mentions that for other the surgeries the evidence is still limited, and suggests lidocaine may be useful as an adjuvant in enhanced recovery protocols. This conclusion disagrees with our summary, where we found no clinically relevant effect for pain management in surgeries in general, which is especially applicable to abdominal surgeries.
  • We found recomendations about the use of this intervention in the guideline ‘Acute pain management: scientific evidence’ [72] from the Australian and New Zealand College of Anaesthetists (ANZCA). In this guideline it is mentioned that intravenous systemic lidocaine improves pain outcomes, length of hospital stay, postoperative nausea and vomiting, and postoperative ileus in abdominal surgeries, it would also improve pain outcomes in spine surgery. This conclusion disagrees with the conclusions reached in this summary, although the guideline recognizes that probably more evidence is needed for the evaluation of the outcomes in spine surgery.
Could this evidence change in the future?
  • It is unlikely that future trials change the conclusions presented in this summary on the outcomes pain at rest at 24 hours, time to first flatus, length of hospital stay and postoperative nausea and vomiting, due to the certainty of the evidence.
  • We conducted a search in the International Clinical Trial Registry Platform of the World Health Organization, and did not find any ongoing trial addressing this question. In a search in PubMed we identified at least 22 [73],[74],[75],
    [76],[77],[78],[79],[80],[81],[82],[83],[84],[85],[86],[87],[88],[89],[90],[91],
    [92],[93],[94] randomized trials that address this issue and are not included in the identified systematic reviews.
  • At least four [95],[96],[97],[98] systematics reviews were identified in the International Prospective Register of Systematic Reviews (PROSPERO) that address this question.

How we conducted this summary

Using automated and collaborative means, we compiled all the relevant evidence for the question of interest and we present it as a matrix of evidence.

Follow the link to access the interactive version: Intravenous lidocaine versus placebo or no treatment on perioperative analgesia

Notes

The upper portion of the matrix of evidence will display a warning of “new evidence” if new systematic reviews are published after the publication of this summary. Even though the project considers the periodical update of these summaries, users are invited to comment in Medwave or to contact the authors through email if they find new evidence and the summary should be updated earlier.

After creating an account in Epistemonikos, users will be able to save the matrixes and to receive automated notifications any time new evidence potentially relevant for the question appears.

This article is part of the Epistemonikos Evidence Synthesis project. It is elaborated with a pre-established methodology, following rigorous methodological standards and internal peer review process. Each of these articles corresponds to a summary, denominated FRISBEE (Friendly Summary of Body of Evidence using Epistemonikos), whose main objective is to synthesize the body of evidence for a specific question, with a friendly format to clinical professionals. Its main resources are based on the evidence matrix of Epistemonikos and analysis of results using GRADE methodology. Further details of the methods for developing this FRISBEE are described here (http://dx.doi.org/10.5867/medwave.2014.06.5997)

Epistemonikos foundation is a non-for-profit organization aiming to bring information closer to health decision-makers with technology. Its main development is Epistemonikos database (www.epistemonikos.org).

Potential conflicts of interest

The authors do not have relevant interests to declare.

Esta obra de Medwave está bajo una licencia Creative Commons Atribución-NoComercial 3.0 Unported. Esta licencia permite el uso, distribución y reproducción del artículo en cualquier medio, siempre y cuando se otorgue el crédito correspondiente al autor del artículo y al medio en que se publica, en este caso, Medwave.

Autores

María Magdalena González

Fernando Altermatt

fernando.altermatt@gmail.com.

Centro Evidencia Uc, Pontificia Universidad Católica de Chile, Centro de Innovación UC Anacleto Angelini, Avda

Figures

Article has no figures.

Foro

No hay mensajes

Historial

Citación González M, Altermatt F. Is intravenous lidocaine effective for decreasing pain and speeding up recovery after surgery?. Medwave 2017;17(09):e7121 doi: 10.5867/medwave.2017.09.7121

Envío 30/11/2017

Aceptación 27/12/2017

Publicación 29/12/2017

Métricas del artículo

Artículo no tiene métricas.

Notas

Provenance and peer review

Con revisión por pares sin ciego por parte del equipo metodológico del Epistemonikos Evidence Synthesis Project.

Referencias

  1. Weibel S, Jokinen J, Pace NL, Schnabel A, Hollmann MW, Hahnenkamp K, Eberhart LH, Poepping DM, Afshari A, Kranke P. Efficacy and safety of intravenous lidocaine for postoperative analgesia and recovery after surgery: a systematic review with trial sequential analysis. Br J Anaesth. 2016 Jun;116(6):770-83. | CrossRef | PubMed
  2. Wallström A, Frisman GH. Facilitating early recovery of bowel motility after colorectal surgery: a systematic review. J Clin Nurs. 2014 Jan;23(1-2):24-44. | CrossRef | PubMed
  3. Vigneault L, Turgeon AF, Côté D, Lauzier F, Zarychanski R, Moore L, McIntyre LA, Nicole PC, Fergusson DA. Perioperative intravenous lidocaine infusion for postoperative pain control: a meta-analysis of randomized controlled trials. Can J Anaesth. 2011 Jan;58(1):22-37. | CrossRef | PubMed
  4. Ventham NT, Kennedy ED, Brady RR, Paterson HM, Speake D, Foo I, Fearon KC. Efficacy of Intravenous Lidocaine for Postoperative Analgesia Following Laparoscopic Surgery: A Meta-Analysis. World J Surg. 2015 Sep;39(9):2220-34. | CrossRef | PubMed
  5. Traut U, Brügger L, Kunz R, Pauli-Magnus C, Haug K, Bucher HC, Koller MT. Systemic prokinetic pharmacologic treatment for postoperative adynamic ileus following abdominal surgery in adults. Cochrane Database Syst Rev. 2008 Jan 23;(1):CD004930. | CrossRef | PubMed
  6. Sun Y, Li T, Wang N, Yun Y, Gan TJ. Perioperative systemic lidocaine for postoperative analgesia and recovery after abdominal surgery: a meta-analysis of randomized controlled trials. Dis Colon Rectum. 2012 Nov;55(11):1183-94. Erratum in: Dis Colon Rectum. 2013 Feb;52(2):271. | CrossRef | PubMed
  7. McCarthy GC, Megalla SA, Habib AS. Impact of intravenous lidocaine infusion on postoperative analgesia and recovery from surgery: a systematic review of randomized controlled trials. Drugs. 2010 Jun 18;70(9):1149-63. | CrossRef | PubMed
  8. Marret E, Rolin M, Beaussier M, Bonnet F. Meta-analysis of intravenous lidocaine and postoperative recovery after abdominal surgery. Br J Surg. 2008 Nov;95(11):1331-8. | CrossRef | PubMed
  9. Kranke P, Jokinen J, Pace NL, Schnabel A, Hollmann MW, Hahnenkamp K, Eberhart LH, Poepping DM, Weibel S. Continuous intravenous perioperative lidocaine infusion for postoperative pain and recovery. Cochrane Database Syst Rev. 2015 Jul 16;(7):CD009642. | CrossRef | PubMed
  10. Khan JS, Yousuf M, Victor JC, Sharma A, Siddiqui N. An estimation for an appropriate end time for an intraoperative intravenous lidocaine infusion in bowel surgery: a comparative meta-analysis. J Clin Anesth. 2016 Feb;28:95-104. | CrossRef | PubMed
  11. Joshi GP, Bonnet F, Kehlet H; PROSPECT collaboration. Evidence-based postoperative pain management after laparoscopic colorectal surgery. Colorectal Dis. 2013 Feb;15(2):146-55. | CrossRef | PubMed
  12. Gholipour Baradari A, Habibi MR, Habibi V, Nouraei SM. Administration of lidocaine to prevent cognitive deficit in patients undergoing coronary artery bypass grafting and valve plasty: a systematic review and meta-analysis. Expert Rev Clin Pharmacol. 2017 Feb;10(2):179-185. | CrossRef | PubMed
  13. Chang YC, Liu CL, Liu TP, Yang PS, Chen MJ, Cheng SP. Effect of Perioperative Intravenous Lidocaine Infusion on Acute and Chronic Pain after Breast Surgery: A Meta-Analysis of Randomized Controlled Trials. Pain Pract. 2017 Mar;17(3):336-343. | CrossRef | PubMed
  14. Barreveld A, Witte J, Chahal H, Durieux ME, Strichartz G. Preventive analgesia by local anesthetics: the reduction of postoperative pain by peripheral nerve blocks and intravenous drugs. Anesth Analg. 2013 May;116(5):1141-61. | CrossRef | PubMed
  15. Dong M, Tian B, Gao S, Yang D, Ren X. A systemic review of the preventative effect of peri-operative intervention to the post mastectomy pain syndrome. Journal of Modern Oncology. 2016;2:248-253. | CrossRef
  16. Baral BK, Bhattarai BK, Rahman TR, Singh SN, Regmi R. Perioperative intravenous lidocaine infusion on postoperative pain relief in patients undergoing upper abdominal surgery. Nepal Med Coll J. 2010 Dec;12(4):215-20. | PubMed
  17. Cassuto J, Wallin G, Högström S, Faxén A, Rimbäck G. Inhibition of postoperative pain by continuous low-dose intravenous infusion of lidocaine. Anesth Analg. 1985 Oct;64(10):971-4. | PubMed
  18. Choi SJ, Kim MH, Jeong HY, Lee JJ. Effect of intraoperative lidocaine on anesthetic consumption, and bowel function, pain intensity, analgesic consumption and hospital stay after breast surgery. Korean J Anesthesiol. 2012 May;62(5):429-34. | CrossRef | PubMed
  19. Cui W, Li Y, Li S, Wang R, Li J. Systemic administration of lidocaine reduces morphine requirements and postoperative pain of patients undergoing thoracic surgery after propofol-remifentanil-based anaesthesia. Eur J Anaesthesiol. 2010 Jan;27(1):41-6. | CrossRef | PubMed
  20. Farag E, Ghobrial M, Sessler DI, Dalton JE, Liu J, Lee JH, Zaky S, Benzel E, Bingaman W, Kurz A. Effect of perioperative intravenous lidocaine administration on pain, opioid consumption, and quality of life after complex spine surgery. Anesthesiology. 2013 Oct;119(4):932-40. | CrossRef | PubMed
  21. Grady MV, Mascha E, Sessler DI, Kurz A. The effect of perioperative intravenous lidocaine and ketamine on recovery after abdominal hysterectomy. Anesth Analg. 2012 Nov;115(5):1078-84. | CrossRef | PubMed
  22. Herroeder S, Pecher S, Schönherr ME, Kaulitz G, Hahnenkamp K, Friess H, Böttiger BW, Bauer H, Dijkgraaf MG, Durieux ME, Hollmann MW. Systemic lidocaine shortens length of hospital stay after colorectal surgery: a double-blinded, randomized, placebo-controlled trial. Ann Surg. 2007 Aug;246(2):192-200. Erratum in: Ann Surg. 2009 Apr;249(4):701. Dijkgraaf, Omarcel G W [corrected to Dijkgraaf, Marcel G W]. | PubMed
  23. Insler SR, O'Connor M, Samonte AF, Bazaral MG. Lidocaine and the inhibition of postoperative pain in coronary artery bypass patients. J Cardiothorac Vasc Anesth. 1995 Oct;9(5):541-6. | PubMed
  24. Kaba A, Laurent SR, Detroz BJ, Sessler DI, Durieux ME, Lamy ML, Joris JL. Intravenous lidocaine infusion facilitates acute rehabilitation after laparoscopic colectomy. Anesthesiology. 2007 Jan;106(1):11-8; discussion 5-6. | PubMed
  25. Kang H, Kim BG. Intravenous lidocaine for effective pain relief after inguinal herniorrhaphy: a prospective, randomized, double-blind, placebo-controlled study. J Int Med Res. 2011;39(2):435-45. | PubMed
  26. Kasten GW, Owens E. Evaluation of lidocaine as an adjunct to fentanyl anesthesia for coronary artery bypass graft surgery. Anesth Analg. 1986 May;65(5):511-5. | PubMed
  27. Kim TH, Kang H, Hong JH, Park JS, Baek CW, Kim JY, Jung YH, Kim HK. Intraperitoneal and intravenous lidocaine for effective pain relief after laparoscopic appendectomy: a prospective, randomized, double-blind, placebo-controlled study. Surg Endosc. 2011 Oct;25(10):3183-90. | CrossRef
  28. Kuo CP, Jao SW, Chen KM, Wong CS, Yeh CC, Sheen MJ, Wu CT. Comparison of the effects of thoracic epidural analgesia and i.v. infusion with lidocaine on cytokine response, postoperative pain and bowel function in patients undergoing colonic surgery. Br J Anaesth. 2006 Nov;97(5):640-6. | PubMed
  29. Lee EH, Lee HM, Chung CH, Chin JH, Choi DK, Chung HJ, Sim JY, Choi IC. Impact of intravenous lidocaine on myocardial injury after off-pump coronary artery surgery. Br J Anaesth. 2011 Apr;106(4):487-93. | CrossRef | PubMed
  30. Kim WJ , Lee EH , Sim JY , Choi IC. Impact of intravenous lidocaine on myocardial injury during off pump coronary artery surgery. Journal of Cardiothoracic and Vascular Anesthesia. 2010. | Link
  31. McKay A, Gottschalk A, Ploppa A, Durieux ME, Groves DS. Systemic lidocaine decreased the perioperative opioid analgesic requirements but failed to reduce discharge time after ambulatory surgery. Anesth Analg. 2009 Dec;109(6):1805-8. | CrossRef | PubMed
  32. Mitchell SJ, Pellett O, Gorman DF. Cerebral protection by lidocaine during cardiac operations. Ann Thorac Surg. 1999 Apr;67(4):1117-24. | PubMed
  33. Mitchell SJ, Merry AF, Frampton C, Davies E, Grieve D, Mills BP, Webster CS, Milsom FP, Willcox TW, Gorman DF. Cerebral protection by lidocaine during cardiac operations: a follow-up study. Ann Thorac Surg. 2009 Mar;87(3):820-5. | CrossRef | PubMed
  34. Omar AM. Can systemic lidocaine be used in controlled hypotension? A double-blinded randomized controlled study in patients undergoing functional endoscopic sinus surgery. Egyptian Journal of Anaesthesia. 2013 Oct;29(4):295-300. | CrossRef
  35. Slovack M, Taylor B, Bryce R, Ong D. Does intravenous lidocaine infusion during video-assisted thoracoscopic surgery reduce postoperative analgesia? A randomized controlled study. Can J Anaesth. 2015 Jun;62(6):676-7. | CrossRef | PubMed
  36. Soltani HA , Nasr M , Siadat ZD. Effects of Lidocaine on Reducing the Need for Anesthetic Drugs during Ophthalmologic Surgeries. Journal of Isfahan Medical School. 2013 Apr;31(224):41-49. | Link
  37. Terkawi AS, Durieux ME, Gottschalk A, Brenin D, Tiouririne M. Effect of intravenous lidocaine on postoperative recovery of patients undergoing mastectomy: a double-blind, placebo-controlled randomized trial. Reg Anesth Pain Med. 2014 Nov-Dec;39(6):472-7. | CrossRef | PubMed
  38. Terkawi AS, Sharma S, Durieux ME, Thammishetti S, Brenin D, Tiouririne M. Perioperative lidocaine infusion reduces the incidence of post-mastectomy chronic pain: a double-blind, placebo-controlled randomized trial. Pain Physician. 2015 Mar-Apr;18(2):E139-46. | PubMed
  39. Tikuišis R, Miliauskas P, Samalavičius NE, Žurauskas A, Samalavičius R, Zabulis V. Intravenous lidocaine for post-operative pain relief after hand-assisted laparoscopic colon surgery: a randomized, placebo-controlled clinical trial. Tech Coloproctol. 2014 Apr;18(4):373-80. | CrossRef | PubMed
  40. Wang D, Wu X, Li J, Xiao F, Liu X, Meng M. The effect of lidocaine on early postoperative cognitive dysfunction after coronary artery bypass surgery. Anesth Analg. 2002 Nov;95(5):1134-41, table of contents. | PubMed
  41. Yang SY, Kang H, Choi GJ, Shin HY, Baek CW, Jung YH, Choi YS. Efficacy of intraperitoneal and intravenous lidocaine on pain relief after laparoscopic cholecystectomy. J Int Med Res. 2014 Apr;42(2):307-19. | CrossRef | PubMed
  42. Yardeni IZ, Beilin B, Mayburd E, Levinson Y, Bessler H. The effect of perioperative intravenous lidocaine on postoperative pain and immune function. Anesth Analg. 2009 Nov;109(5):1464-9. | CrossRef | PubMed
  43. Birch K, Jørgensen J, Chraemmer-Jørgensen B, Kehlet H. Effect of i.v. lignocaine on pain and the endocrine metabolic responses after surgery. Br J Anaesth. 1987 Jun;59(6):721-4. | PubMed
  44. Bryson GL, Charapov I, Krolczyk G, Taljaard M, Reid D. Intravenous lidocaine does not reduce length of hospital stay following abdominal hysterectomy. Can J Anaesth. 2010 Aug;57(8):759-66. | CrossRef | PubMed
  45. Cepeda MS, Delgado M, Ponce M, Cruz CA, Carr DB. Equivalent outcomes during postoperative patient-controlled intravenous analgesia with lidocaine plus morphine versus morphine alone. Anesth Analg. 1996 Jul;83(1):102-6. | PubMed
  46. Chia YY, Tan PH, Wang KY, Liu K. Lignocaine plus morphine in bolus patient-controlled intravenous analgesia lacks post-operative morphine-sparing effect. Eur J Anaesthesiol. 1998 Nov;15(6):664-8. | PubMed
  47. De Kock M, Lavandhomme P, Scholtes JL. Intraoperative and postoperative analgesia using intravenous opioid, clonidine and lignocaine. Anaesth Intensive Care. 1994 Feb;22(1):15-21. | PubMed
  48. De Oliveira GS Jr, Duncan K, Fitzgerald P, Nader A, Gould RW, McCarthy RJ. Systemic lidocaine to improve quality of recovery after laparoscopic bariatric surgery: a randomized double-blinded placebo-controlled trial. Obes Surg. 2014 Feb;24(2):212-8. | CrossRef | PubMed
  49. De Oliveira GS Jr, Fitzgerald P, Streicher LF, Marcus RJ, McCarthy RJ. Systemic lidocaine to improve postoperative quality of recovery after ambulatory laparoscopic surgery. Anesth Analg. 2012 Aug;115(2):262-7. | CrossRef | PubMed
  50. El-Tahan MR, Warda OM, Diab DG, Ramzy EA, Matter MK. A randomized study of the effects of perioperative i.v. lidocaine on hemodynamic and hormonal responses for cesarean section. J Anesth. 2009;23(2):215-21. | CrossRef | PubMed
  51. Grady P, Clark N, Lenahan J, Oudekerk C, Hawkins R, Nezat G, Pellegrini JE. Effect of intraoperative intravenous lidocaine on postoperative pain and return of bowel function after laparoscopic abdominal gynecologic procedures. AANA J. 2012 Aug;80(4):282-8. | PubMed
  52. Grigoras A, Lee P, Sattar F, Shorten G. Perioperative intravenous lidocaine decreases the incidence of persistent pain after breast surgery. Clin J Pain. 2012 Sep;28(7):567-72. | CrossRef | PubMed
  53. Groudine SB, Fisher HA, Kaufman RP Jr, Patel MK, Wilkins LJ, Mehta SA, Lumb PD. Intravenous lidocaine speeds the return of bowel function, decreases postoperative pain, and shortens hospital stay in patients undergoing radical retropubic prostatectomy. Anesth Analg. 1998 Feb;86(2):235-9. | PubMed
  54. Harvey KP, Adair JD, Isho M, Robinson R. Can intravenous lidocaine decrease postsurgical ileus and shorten hospital stay in elective bowel surgery? A pilot study and literature review. Am J Surg. 2009 Aug;198(2):231-6. | CrossRef | PubMed
  55. Ismail SA. Effects of systemic lidocaine infusion during lumbar discectomy under total intravenous anesthesia. Egyptian Journal of Anaesthesia. 2008 Jan;24(1):39-46. | Link
  56. Juárez-Pichardo JS, Ávila-López A, Serrano-Herrera MA. Preventive postoperative analgesia with dexmetomidine iv compared to lidocaine iv in cholecystectomy. Rev Mex Anest. 2009 Apr-Jun;32(2):81-88. | Link
  57. Kim HO, Lee SR, Choi WJ, Kim H. Early oral feeding following laparoscopic colorectal cancer surgery. ANZ J Surg. 2014 Jul-Aug;84(7-8):539-44. | CrossRef | PubMed
  58. Kim TH, Kang H, Choi YS, Park JM, Chi KC, Shin HY, Hong JH. Pre- and intraoperative lidocaine injection for preemptive analgesics in laparoscopic gastrectomy: a prospective, randomized, double-blind, placebo-controlled study. J Laparoendosc Adv Surg Tech A. 2013 Aug;23(8):663-8. | CrossRef | PubMed
  59. Koppert W, Weigand M, Neumann F, Sittl R, Schuettler J, Schmelz M, Hering W. Perioperative intravenous lidocaine has preventive effects on postoperative pain and morphine consumption after major abdominal surgery. Anesth Analg. 2004 Apr;98(4):1050-5, table of contents. | PubMed
  60. Lauwick S, Kim DJ, Mistraletti G, Carli F. Functional walking capacity as an outcome measure of laparoscopic prostatectomy: the effect of lidocaine infusion. Br J Anaesth. 2009 Aug;103(2):213-9. | CrossRef | PubMed
  61. Martin F, Cherif K, Gentili ME, Enel D, Abe E, Alvarez JC, Mazoit JX, Chauvin M, Bouhassira D, Fletcher D. Lack of impact of intravenous lidocaine on analgesia, functional recovery, and nociceptive pain threshold after total hip arthroplasty. Anesthesiology. 2008 Jul;109(1):118-23. | CrossRef | PubMed
  62. Mathew JP, Mackensen GB, Phillips-Bute B, Grocott HP, Glower DD, Laskowitz DT, Blumenthal JA, Newman MF; Neurologic Outcome Research Group (NORG) of the Duke Heart Center. Randomized, double-blinded, placebo controlled study of neuroprotection with lidocaine in cardiac surgery. Stroke. 2009 Mar;40(3):880-7. | CrossRef | PubMed
  63. Rimbäck G, Cassuto J, Tollesson PO. Treatment of postoperative paralytic ileus by intravenous lidocaine infusion. Anesth Analg. 1990 Apr;70(4):414-9. | PubMed
  64. Rinne T, Kaukinen S. Does lidocaine protect the heart during coronary revascularisation? Acta Anaesthesiol Scand. 1998 Sep;42(8):936-40. | PubMed
  65. Saadawy IM, Kaki AM, Abd El Latif AA, Abd-Elmaksoud AM, Tolba OM. Lidocaine vs. magnesium: effect on analgesia after a laparoscopic cholecystectomy. Acta Anaesthesiol Scand. 2010 May;54(5):549-56. | CrossRef | PubMed
  66. Striebel HW, Klettke U. [Is intravenous lidocaine infusion suitable for postoperative pain management?]. Schmerz. 1992 Dec;6(4):245-50. German. | PubMed
  67. Wallin G, Cassuto J, Högström S, Lindén I, Faxén A, Rimbäck G, Hedner T. Effects of lidocaine infusion on the sympathetic response to abdominal surgery. Anesth Analg. 1987 Oct;66(10):1008-13. | PubMed
  68. Wu CT, Borel CO, Lee MS, Yu JC, Liou HS, Yi HD, Yang CP. The interaction effect of perioperative cotreatment with dextromethorphan and intravenous lidocaine on pain relief and recovery of bowel function after laparoscopic cholecystectomy. Anesth Analg. 2005 Feb;100(2):448-53. | PubMed
  69. Wuethrich PY, Romero J, Burkhard FC, Curatolo M. No benefit from perioperative intravenous lidocaine in laparoscopic renal surgery: a randomised, placebo-controlled study. Eur J Anaesthesiol. 2012 Nov;29(11):537-43. | CrossRef | PubMed
  70. Yin LZ. The effect of multimodal analgesia in chronic postoperative pain after modified radical mastectomy. Capital Medical University. 2013. | Link
  71. Dunn LK, Durieux ME. Perioperative Use of Intravenous Lidocaine. Anesthesiology. 2017 Apr;126(4):729-737. | CrossRef | PubMed
  72. Schug SA, Palmer GM, Scott DA, Halliwell R, Trinca J. Acute pain management: scientific evidence, fourth edition, 2015. Med J Aust. 2016 May 2;204(8):315-7. | PubMed
  73. Govindarajan R. Efficacy of Intravenous Lidocaine in the Operative Management of Thyroid Surgery With Intraoperative Nerve Monitoring. Clinical trials [Online] | Link
  74. Shah A. Efficacy of Intravenous Lidocaine in the Operative Management of Thyroid Surgery With Intraoperative Nerve Monitoring. Clinical trials [Online] | Link
  75. Plattner V. E L I C O : Evaluation de la Lidocaïne par voie Intraveineuse en chirurgie Carcinologique ORL Essai thérapeutique randomisé, contrôlé, en double aveugle, versus placebo évaluant l'épargne morphinique et la douleur chronique postopératoire. Clinical trials [Online] | Link
  76. Herzog J. Randomized, double-blind, prospective, placebo-controlled trial of the effect of intravenous lidocaine infusion for postoperative pain management and bowel function in robot assisted laparoscopic colon surgery. Clinical trials [Online] | Link
  77. Sahmeddini MA. Comparison the effect of intraoperative ketamine and systemic lidocaine on post operative pain management of opioid dependent patients undergoing orthopedic surgeries. Clinical trials [Online] | Link
  78. Choi YJ. Effect of oxynorm on postoperative pain and recovery from anesthesia in patients undergoing thyroidectomy. Clinical trials [Online] | Link
  79. Yoo Y. The Impact of Intraoperative Systemic Lidocaine Infusion on Chronic Postoperative Pain After Video-assisted Thoracic Surgery (VATS). Clinical trials [Online] | Link
  80. Anesthesia research. Systemic administration of Lidocain for oncological gynaecological surgery: the effect on postoperative pain and consumption of Morphine. Clinical trials [Online] | Link
  81. Karlnoski R. Systemic Intraoperative Lidocaine Infusion for Postoperative Pain Management in Obese Patients: A Randomized, Placebo-Controlled Pilot Study. Clinical trials [Online] | Link
  82. Head of Department Anesthesiology. Pilot study: Targeting the inflammatory response and the induction of acute pain after breast cancer surgery with perioperative infusion of lidocaine. Clinical trials [Online] | Link
  83. Hajduk J. Intravenous Lidocaine to Decrease Postoperative Pain in Pediatric Patients Undergoing Tonsillectomy: A Randomized, Double Blind, Placebo Controlled Trial. Clinical trials [Online] | Link
  84. Tiouririne M. IRB-HSR# 13957: IV Lidocaine for Patients Undergoing Primary Breast Cancer Surgery: Effects on Postoperative Recovery and Cancer Recurrence. Clinical trials [Online] | Link
  85. Mahajan C. Effect of magnesium and lignocaine on postcraniotomy pain: a comparative, randomised, double-blinded, placebo-controlled study. Clinical trials [Online] | Link
  86. Trivedi D. The Effect of Perioperative Intravenous Lidocaine on Postoperative Outcomes After Cardiac Surgery. Clinical trials [Online] | Link
  87. L’intérêt de la Xylocaine® et de la kétamine per et postopératoire sur la prise en charge de la douleur postopératoire aigue et chronique après colectomie par Laparoscopie. Clinical trials [Online] | Link
  88. Logvinov I. Perioperative Intravenous Lidocaine Infusion for Patients Undergoing Laparoscopic and Open Pancreatectomies. Clinical trials [Online] | Link
  89. El-Tahan M. Perioperative Systemic Lidocaine for Enhanced Bowel Recovery After Laparoscopic Bariatric Surgery: A Dose Dependent Study. Clinical trials [Online] | Link
  90. Chuxiong P. Effect of Intravenous Lidocaine on Postoperative Pain Management After Laparoscopy Cholecystectomy. Clinical trials [Online] | Link
  91. Ni J. Effect of intravenous lidocaine for postoperative catheter-related bladder discomfort in patients undergoing gynecological laparotomy. Clinical trials [Online] | Link
  92. Deem S. Intravenous Lidocaine in the Perioperative Setting and the Effects on Postoperative Pain and Bowel Function Following Cystectomy: A Pilot Study. Clinical trials [Online] | Link
  93. Lebuffe G. The Interest of the Xylocaine® and Ketamine on the Per and Postoperative Management of Acute and Chronic Postoperative Pain After Colectomy by Laparoscopy. Clinical trials [Online] | Link
  94. Sun Y. Intravenous Lidocaine and Postoperative Pain Management. Clinical trials [Online] | Link
  95. Rehberg B, Tramèr M, Iselin-Chavez I, Elia N. Efficacy and harm of non-opioid analgesics that are used concomitantly with opioids in the perioperative period: systematic review of systematic reviews. Prospero [Online] | Link
  96. Moppett I. Intraoperative, intravenous lidocaine for prevention of adverse outcomes following surgery: systematic review and meta-analysis. Prospero [Online] | Link
  97. Li Y. The effectiveness of lidocaine for preventing postoperative cognitive dysfunction: a systematic review and meta-analysis. Prospero [Online] | Link
  98. Ventham N. IV lidocaine and return of gut function in colorectal surgery. Prospero [Online] | Link